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Abstract
The present investigations sought to determine whether the ventral tegmental area (VTA),
basolateral amygdala (BLA), and nucleus accumbens shell (NAC) comprise a circuitry that
mediates heroin-induced conditioned immunomodulation. Rats were given conditioning trials in
which they received an injection of heroin upon placement into a distinctive environment. Prior to
testing, rats received unilateral intra-BLA microinfusion of a D1 antagonist concomitantly with
unilateral intra-NAC shell microinfusion of an NMDA antagonist. Disconnection of the VTA-
BLA-NAC circuit impaired the ability of the heroin-paired environment to suppress
lipopolysaccharide-induced immune responses, defining for the first time a specific neural circuit
involved in conditioned neural-immune interactions.
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1. Introduction
Opioid treatment in rats suppresses a number of in vivo immune responses, including the
production of nitric oxide, a key component of host defense against bacterial infection (e.g.,
Fecho et al., 1996a; 1996b; Lysle et al., 1993; Lysle & How, 2000; Nelson et al., 2000). In
addition, opioid drugs also suppress in vivo expression of proinflammatory cytokines (Chao
et al 1993; Bencsics et al 1997; Pacifici et al 2000; Clark et al., 2007). Proinflammatory
cytokines, such as IL-6 and TNF-α, play critical roles in the body’s defense against
infectious challenge, while also serving to regulate the immune response to these challenges.
There is now substantial evidence that these effects of opioid drugs on the immune system
are generated via actions within the CNS. For example, intraventricularly administered N-
methylnaltrexone (an opioid antagonist that does not readily cross the blood-brain barrier)
dose-dependently antagonizes the immunomodulatory effects of systemic morphine
administration, whereas peripheral administration of N-methylnaltrexone is ineffective in
blocking morphine’s effects (Lysle et al., 1996; Fecho et al., 1996a). Furthermore,
microinjection of morphine into the periacqueductal gray results in suppression of NK cell
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cytotoxicity which can be blocked by peripheral administration of naltrexone, an opioid
antagonist (Weber & Pert, 1989). Remarkably, the suppressive effects of opioids on the
immune system can be conditioned to environmental stimuli paired with drug administration
(Lysle & Ijames, 2002) such that the previously heroin-paired environment alone elicits
heroin-like changes in immune functioning. Conditioned immune alterations brought about
by exposure to drug cues may manifest as an increased susceptibility to opportunistic
infections and a decreased ability to combat infectious diseases in recovering drug users. A
clear understanding of the neurotransmitters and neural circuitry involved in heroin-
conditioned immunomodulation is necessary for the development of pharmacotherapeutic
interventions that might be employed in susceptible populations before infections lead to
irreversible organ damage and other detrimental health consequences.
Recent studies in our laboratory and others have identified key brain structures involved in
the mediation of conditioned immunomodulation. For example, several brain structures are
critically involved in the expression and acquisition of immune alterations in a conditioned
taste aversion model. These include the insular cortex, amygdala and the ventromedial
nucleus of the hypothalamus (Chen et al., 2004; Pacheco-Lopez et al., 2005; Ramirez-
Amaya & Bermudez-Rattoni, 1999; Ramirez-Amaya et al., 1998; Ramirez-Amaya et al.,
1996). Our own laboratory recently demonstrated that dopamine neurotransmission in the
basolateral amygdala (BLA) and nucleus accumbens shell (NAC) is necessary for heroin-
conditioned and morphine-conditioned immunomodulation, respectively (Szczytkowski &
Lysle, 2008; Saurer et al., 2009). Specifically, D1 dopaminergic receptor antagonism in
these structures inhibits conditioned decreases in the production of proinflammatory
mediators in peripheral immune tissues (Szczytkowski & Lysle, 2010). This implies that the
ventral tegmental area (VTA), the primary source of dopamine to the BLA in the rat (Ford et
al., 2006), is an element of the neural circuitry mediating heroin-conditioned immune
regulation. In addition to dopamine, glutamate input to the NAC is important for conditioned
behaviors. For instance, AMPA or NMDA receptor antagonism in the NAC disrupts 7-OH-
DPAT conditioned place preference (Biondo et al., 2005) and AMPA antagonism in the
NAC inhibits cocaine context-induced drug seeking behavior (Xie et al., 2011). Despite
these significant findings regarding the contributions of individual brain regions, no attempt
has been made to identify functionally significant connections between these brain regions
thus to map the neural circuitry responsible for heroin-induced conditioned
immunomodulation, specifically, or for conditioned immune alterations, in general. Given
the critical role of dopamine in the BLA in conditioned immunomodulation and the
existence of glutamatergic BLA afferents to the NAC (Kelley et al, 1982; McDonald, 1991;
Wright et al, 1996), we hypothesized that the VTA-BLA-NAC circuitry may control the
conditioned effects of heroin on immune measures.
To begin testing this hypothesis, we first evaluated whether ionotropic glutamate receptor
antagonism in the NAC shell would block heroin-conditioned suppression of nitric oxide
and the proinflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-6
(IL-6), in response to a lipopolysaccharide (LPS) immune challenge. Research has shown a
role for both NMDA and AMPA/kainate receptors in various drug-conditioned responses
(Hotsenpiller et al., 2001; Rodriguez-Borrero et al., 2006; Backstrom & Hyytia, 2007).
Therefore, we investigated whether either of these receptors in the NAC shell contributes to
conditioned immunomodulation.
The results of experiment 1 supported the hypothesis that glutamatergic input in the NAC
shell regulates conditioned immunomodulation and set the stage for experiment 2 in which
we tested the hypothesis that communication within the VTA-BLA-NAC circuitry, via the
stimulation of D1 dopamine receptors in the BLA and NMDA receptors in the NAC, is
necessary for the expression of conditioned immunomodulation. This experiment took
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advantage of the functional disconnection procedure which has been utilized previously to
demonstrate the serial connectivity between brain regions necessary for the expression of
motivated behavior in animal models of addiction (Di Ciano & Everitt, 2004; Fuchs et al.,
2007; Belin & Everitt, 2008; Lasseter et al., 2011). The premise of the functional
disconnection procedure is that unilateral antagonism of one brain region combined with
contralateral antagonism of another brain region produces greater functional impairment
than ipsilateral antagonism of these brain regions if, in fact, intrahemispheric interactions
between these brain structures are functionally necessary (Parkinson et al., 2000). This
research endeavor was undertaken to explore, for the first time, the involvement of a multi-
synaptic neural circuit in the control of neural-immune interactions and, specifically, in the
expression of heroin-induced conditioned immune alterations.
2. Materials and Methods
Animals
Male Lewis rats, weighing 225–250 g, were purchased from Charles River Laboratories
(Raleigh, N.C., USA). Animals were housed individually in plastic cages in a colony room
with a reversed light-dark (12h) cycle maintained through artificial illumination. Access to
food and water was given ad libitum throughout the experiment except for the time spent in
the conditioning chambers when food and water were not available. Animals were given a 2-
week habituation period before the start of experimental manipulations and were handled
regularly during this time. All procedures were approved by the IACUC of the University of
North Carolina at Chapel Hill and conformed to National Institutes of Health (NIH)
Guidelines on the Care and Use of Laboratory Animals.
Surgical Procedure
Animals were anesthetized with 0.35 ml intramuscular injections of 9:1 (vol/vol) ketamine
hydrochloride (100 mg/ml) mixed with xylazine (100 mg/ml) and placed into the stereotaxic
apparatus. Animals were implanted with 26-gauge bilateral guide cannula (Plastics One,
Roanoke, VA) directed unilaterally toward the BLA (AP −2.5, ML±5.0, DV −6.6) and/or
bilaterally towards the NAC shell (AP +1.7, ML ±0.8, DV −5.4). Coordinates are expressed
as millimeters from bregma (Paxinos & Watson, 1986). Animals were given two weeks to
recover from surgery before the start of conditioning trials.
Classical Conditioning Procedure
To condition heroin’s immunomodulatory effects, all animals received five 60-min training
sessions in which they received a subcutaneous injection of heroin (diacethylmorphine, 1
mg/kg, sc; NIDA Drug Supply System, Bethesda, MD), dissolved in 0.9 % sterile saline,
immediately prior to placement into a standard conditioning chamber. This heroin dose was
selected based on prior experiments in our laboratory showing that it induces conditioned
alterations in LPS-induced iNOS and TNF-α mRNA expression in spleen tissue (Lysle &
Ijames, 2002; Szczytkowski & Lysle, 2007). Training sessions were separated by 48 h.
The conditioning chambers (BRS/LVE, Laurel, MD, USA) were located in a room separate
from the animal colony and contained a metal grid floor and cedar bedding to create an
environment distinct from the home cage. All conditioning took place during the dark phase
of the light cycle and the conditioning chambers were kept dark. Previous studies have
shown that animals that undergo this procedure and are later exposed to the previously
heroin-paired environment demonstrate robust suppression of immunological parameters,
including reduced nitric oxide production and proinflammatory cytokine expression (Lysle
& Ijames, 2002; Szczytkowski & Lysle, 2008; 2010).
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Six days following the final conditioning session, animals were re-exposed to the
conditioned stimulus (i.e., the conditioning chambers) without further drug administration to
determine whether the conditioned stimulus alone would induce alterations in
proinflammatory mediators. Thirty minutes prior to the test session, animals received
bilateral intra-NAC microinfusions of an ionotropic glutamate antagonist (AMPA/kainate
receptor antagonist: CNQX, 2.5 µg/0.5 µl/hemisphere; or NMDA receptor antagonist: AP-5,
1.0 µg/0.5 µl/ hemisphere; Experiment 1) or a unilateral microinfusion of the D1 antagonist,
SCH23390 (2 µg/0.5 µl/hemisphere), into the BLA concomitant with either an ipsilateral or
contralateral microinfusion of the NMDA receptor antagonist, AP-5 (1.0 µg/0.5 µl/
hemisphere) into the NAC shell (Experiment 2). Control animals received microinfusions of
saline vehicle (0.5 µl/ hemisphere infused). The antagonist doses and volumes were chosen
based upon previous behavioral/immunological studies that had shown attenuation of cue-
induced drug seeking and opioid-induced conditioned immunomodulation at these doses/
volumes of antagonists (Szczytkowski & Lysle, 2010; Saurer et al., 2006; Giertler et al.,
2005) and the results of experiment 1. Injector cannulae extended 2 mm beyond the tip of
the guide cannulae and were left in place for 1 minute after the injection to allow for proper
drug diffusion.
Following the microinfusions, two groups of animals were re-exposed to the conditioning
chambers (conditioned stimulus, CS) for 60-min in the absence of heroin. The remaining
two groups of animals (home cage, HC) were returned to their home cages to serve as
controls. After the 60-min session in the conditioning chamber or home cage, all animals
received a systemic LPS injection (1000 µg/kg, sc) to induce iNOS, TNF-α and IL-6
production and were then returned into their home cages. LPS treatment was used in all
groups to produce an immune challenge, as detection of these cytokines and nitric oxide is
limited in the absence of an antigenic challenge. Six hours after LPS administration, all
animals were sacrificed and samples of spleen tissue and blood were collected for analysis.
Spleen tissue was collected because LPS reliably elicits the production nitric oxide in a
number of immune cells, including eosinophils, within the spleen (Bandaletova et al., 1993).
The 6-hr time point was selected based on previous research in our laboratory showing
maximal iNOS induction six hours following LPS administration (Lysle & How, 2000).
Previous studies in our laboratory have included control groups that were exposed to the CS
paired with saline during training and animals that received heroin unpaired with the CS
(Lysle and Ijames, 2002; Szczytkowski & Lysle, 2007). Since these controls were not
significantly different from animals that were not re-exposed to the CS on test day (HC) they
were not included in the current study.
Brain Histology
To assess cannula placement, Alcian blue dye was microinfused into the NAC shell and/or
BLA following sacrifice. Brains were then extracted and post-fixed in a 4%
paraformaldehyde solution. Following fixation, the brains were transferred to a 30% sucrose
solution for cryoprotection and then frozen at −80° C until further analysis. The brains were
sectioned in the coronal plane (50 µm) and were stained using cresyl violet. Cannula
placement was examined on cresyl-violet stained sections and was recorded on appropriate
plates of the rat brain atlas of Paxinos and Watson (1997).
Measurement of the Proinflammatory Immune Response
To determine iNOS, IL-6, and TNF-α expression, real time RT-PCR was performed on
tissue samples from the spleen. The spleen was selected for analysis because
immunohistochemical localization of iNOS in rats exposed to LPS shows the presence of the
iNOS enzyme in a number of immune cells, including macrophages, lymphocytes, and
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neutrophils (Bandaletova et al., 1993). In addition, splenic macrophages also produce IL-6
and TNF-α when activated by LPS. Total RNA was extracted from a section of each of the
tissues using TRI-Reagent (Molecular Research Center, Cincinnati, OH), a modification of
the original method described by Chomczynski and Sacchi (1987). RNA was quantified
spectrophotometrically (GeneQuant II, Pharmacia-Biotech, Piscataway, NJ, USA). For RT-
PCR, reverse transcription was performed using Oligo(dT)18 primer and Moloney Murine
Leukemia Virus-Reverse transcriptase following the protocol of the Advantage RT-for-PCR
Kit from Clontech (Palo Alto, CA, USA).
Specific products from the PCR reaction were detected with Universal ProbeLibrary Probes
(Roche, Indianapolis, IN). In this method, PCR amplifications are performed using standard
protocols, the LightCycler TaqMan Master Real-Time PCR Kit, and the LightCycler
instrument (Roche, Indianapolis, IN). A master mix containing all reaction components was
prepared for all reactions, with each reaction using a 20 ml mix placed in glass capillary
tubes specifically designed for use in the LightCycler system. Primers and probes for genes
of interest were as follows: IL-6, 5’-cctggagtttgtgaagaacaact-3’ and 5’-
ggaagttggggtaggaagga-3’ using probe #106; iNOS, 5’tgaggattacttcttccagctca-3’ and 5’-
tgggtgtcagagtcttgtgc-3’ using probe #25; and TNF-α, 5’-gggcctccagaactccag-3’ and 5’-
gagcccatttgggaacttct-3’ using probe #98. Primers were synthesized by the Nucleic Acids
Core Facility (Lineberger Cancer Center, UNC-Chapel Hill). Copy numbers were generated
from by an internal standard curve. Amplifications were carried out for 45 cycles and curves
showing fluorescence at each cycle were determined by the computer software (Roche).
Samples were pre-incubated for 10 minutes at 95° C to activate the Fast-Start Taq DNA
polymerase. The cycle temperatures were 95 and 60°C for the denaturing and annealing/
extending, respectively. The cycle times were 10 and 30 s for the denaturing and annealing/
extending, respectively. Fluorescence level was determined at the end of the extending
phase for each cycle of PCR. A final cooling phase was carried out at 40 °C for 30s. The
analysis of the fluorescence level in standards and samples over the course of 45 cycles was
used to derive the number of copies of the target molecule in each sample. Additionally,
assessments of housekeeping gene expression, L13A, were made to assure comparable
quality of RNA among samples. L13A primers were 5’-ccctccaccctatgacaaga-3’ and 5’-
ggtacttccacccgacctc-3’ with probe #74. The data are expressed as a ratio of copy number of
iNOS (per 10ng cDNA) to the housekeeping gene, L13A (per 10 ng cDNA), based on the
standard curve using the Lightcycler software (Roche).
To assess IL-6 and TNF-α protein levels, protein was extracted from a section of each
homogenized tissue using freeze/thaw lysis in tris-buffer containing antiproteinases. Protein
was quantified spectrophotometrically (Bio-Tek, Model EL312 kinetic reader, Winooski,
VT, USA) using Bio-Rad protein dye. To account for variability in tissue size, samples were
normalized per unit protein based on the results of the spectrophotometric analysis. The
Invitrogen (Carlsbad, CA) rat TNF-α and IL-6 ELISA test kits were used to determine the
levels of TNF-α and IL-6 protein in each tissue sample. Briefly, samples and standards were
added to microtiter wells coated with antibody that recognizes IL-6 or TNF-α and incubated
at room temperature. Wells were washed extensively and then incubated with biotinylated
antibody, followed by a second wash and then incubation with Streptavidin-HRP. After the
final wash, a chromagen substrate solution was added which reacted with the bound enzyme
to produce color. The color intensity developed proportionally to the amount of IL-6 or
TNF-α present in each sample. The enzyme reaction was stopped after 30 minutes, and the
absorbance at 450 nm was measured with a Bio-Tek (Winooski, VT) Model EL312 kinetic
reader. A standard curve was obtained by plotting the absorbance versus the corresponding
concentrations of the supplied standards.
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The level of nitrite/nitrate in plasma samples was assessed using the Greiss reagent assay.
Nitrate and nitrite are formed non-enzymatically when nitric oxide is exposed to oxygen,
thus plasma levels of these products indicate the level of nitric oxide production. Total
nitrite/nitrate level is determined by the conversion of nitrate to nitrite utilizing nitrate
reductase in the presence of NADPH and flavin adenine dinucleotide, and then an
assessment using Greiss reagent. Briefly, 6 µl of plasma diluted in 44 µl of dH2O is
incubated in the dark for 90-min with 10 µl of nitrate reductase (1.0 unit/ml), 20 µl of a 0.31
M phosphate buffer (ph 7.5), 10 µl of 0.86 mM NADPH (Sigma), and 10 µl of a 0.11 mM
flavin adenine dinucleotide in individual wells of a 96-well plate. Then, 200 ml of Griess
reagent consisting of a 1:1 (v/v) solution 1% sulfanilamide in 5.0% phosphoric acid and
0.1% N-(1-napthyl) ethyl-enedamine dihydrochloride in distilled water was added to the
samples. The color developed for ten minutes at room temperature after which the
absorbance was determined using a spectrophotometer set at 550 nm. All reactions were
carried out in triplicate. The total micromolar concentration of nitrite is determined for each
sample based on a standard curve. Recovery of nitrate is greater than 95% using this assay.
Statistical Analysis
Analysis of variance (ANOVA) was performed on all data sets with antagonist treatment
(saline, AP-5, CNQX, ipsilateral SCH23390+AP-5, contralateral SCH23390+AP-5) and
context (Home Cage, CS Exposed) as between-subjects factors, as appropriate. Statistically
significant interaction effects were followed up by simple main effects tests (t tests) and
planned comparisons evaluating direction-specific hypotheses (one-tail t tests). All analyses
were conducted with the level of significance set at p < 0.05.
3. Results
Histology
Figure 1 presents a schematic representation of the cannula placement for both experiments.
The symbols on the schematics (Paxinos and Watson, 1997) represent the most ventral point
of the infusion cannula tracts for rats that received bilateral microinfusions into the NAC
shell for experiment 1 or unilateral microinfusions into the BLA plus the contralateral or
ipsilateral NAC for experiment 2. Cannula placements were located in the ventral aspect of
the BLA and the ventromedial aspect of the NAC, as intended, in order to minimize
diffusion into unintended brain regions. The data of animals with cannula placement outside
of the BLA or NAC were not included in the statistical analyses. The resulting sample sizes
per group were as follows: bilateral NAC shell Saline/home cage (n=4), bilateral NAC shell
Saline/heroin-paired context (n=5), bilateral NAC shell AP-5/home cage (n=5), bilateral
NAC shell AP-5/heroin-paired context (n=5), bilateral NAC shell CNQX/home cage (n=4),
bilateral NAC shell CNQX/heroin-paired context (n=5), ipsilateral Saline/home cage (n=5),
ipsilateral Saline/heroin-paired context (n=5), contralateral SCH23390+AP-5/home cage
(n=5), contralateral SCH23390+AP-5/heroin-paired context (n=5), ipsilateral
SCH23390+AP-5/home cage (n=5), and ipsilateral SCH23390+AP-5/heroin-paired context
(n=5).
Heroin-conditioned suppression of nitric oxide induction requires the stimulation of
ionotropic glutamate receptors in the nucleus accumbens shell
The first study investigated the effect of bilateral intra-NAC shell microinfusions of the
NMDA glutamate receptor antagonist, AP-5, or the AMPA/kainate glutamate receptor
antagonist, CNQX, on the expression of heroin-conditioned suppression of proinflammatory
mediators. Six days following the final conditioning session, animals were re-exposed to the
previously heroin-paired environment (CS Exposed) or remained in their home cages (Home
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Cage) for 60 min. AP-5, CNQX, or saline was administered 30 minutes prior to the test
session, whereas LPS was administered 1 hr after the test session.
Figure 2 shows the effects of AP-5 and CNQX on the LPS-induced expression of splenic
iNOS mRNA levels (upper panel) and serum nitrite/nitrate levels (lower panel) in the groups
exposed to the previously heroin-paired environment or the home cage prior to LPS
challenge. Because nitric oxide is a gaseous molecule with a short half-life, its production
was measured indirectly by analyzing iNOS enzyme mRNA levels in the spleen and the
degradation products nitrite and nitrate in the serum. The ANOVA for LPS-induced iNOS
copy number in the spleen revealed a significant antagonist by context interaction effect
[F(2,21) = 4.537, P<0.05], but no main effects of antagonist treatment or context. In
addition, a separate ANOVA for serum nitrite/nitrate levels revealed a significant antagonist
by context interaction effect [F(2,21)=10.123, P<0.01) as well as significant main effects of
antagonist treatment [F(2,21)=4.629, P<0.05] and context [F(1,21)=8.593; P<0.01]. The
saline-treated group exposed to the previously heroin-paired environment exhibited lower
splenic iNOS mRNA levels and serum nitrite/nitrate concentration than the saline-treated
home cage control group (t(6)=2.878; P<0.05; t(6)=5.788; P<0.01, respectively). These
changes were similar in intensity to the unconditioned suppression observed following the
administration of heroin itself (Lysle & How, 2000). Most importantly, unlike in the saline-
treated groups, there were no significant differences between the AP-5-treated or the
CNQX-treated group exposed to the previously heroin-paired environment and their
respective home cage control group in splenic iNOS mRNA levels and serum nitrite/nitrate
concentration. These results demonstrate that NMDA or AMPA/kainate receptor antagonism
in the NAC shell blocks the heroin-conditioned suppression in iNOS mRNA expression and
nitrite/nitrate concentration, suggesting a role for these receptors in heroin-induced
conditioned immunomodulation.
Heroin-conditioned suppression of TNF-α production requires the stimulation of
ionotropic glutamate receptors in the nucleus accumbens shell
Exposure to a previously heroin-paired environment induces a conditioned suppression of
the proinflammatory cytokine, TNF-α (Szczytkowski & Lysle, 2008). Figure 3 illustrates
that this conditioned suppressive effect of heroin on TNF-α expression is blocked by
antagonism of glutamate AMPA/kainate or NMDA receptors within the NAC shell. The
ANOVA for splenic TNF-α mRNA levels revealed an antagonist treatment by context
interaction effect [F(2,21)=3.831, p<0.05] but no antagonist treatment or context main
effects. Similarly, the ANOVA for splenic TNF-α protein levels revealed an antagonist
treatment by context interaction effects [F(2,21)=3.737, p<0.05] and an antagonist treatment
main effect [F(2,21)=3.901, p<0.05] but no context main effect. In line with our previous
experiments, the saline-treated group exposed to the previously heroin-paired environment
exhibited significantly lower levels of TNF-α mRNA and protein in the spleen as compared
to the saline-treated home cage control group (one-tail t(6)=1.995; P<0.05; t(6)=2.514;
P<0.05, respectively). Most importantly, unlike in the saline-treated groups, there were no
significant differences between the AP-5-treated or the CNQX-treated group exposed to the
previously heroin-paired environment and the respective home cage control group in TNF-α
mRNA and protein levels in the spleen. These data indicate that NMDA or AMPA/kainate
receptor antagonism in the NAC shell attenuated the heroin-conditioned suppression in LPS-
induced TNF-α expression.
Heroin-conditioned suppression of IL-6 production requires the stimulation of ionotropic
glutamate receptors in the nucleus accumbens shell
Figure 4 shows that the suppressive effect of heroin on the production of the
proinflammatory cytokine, IL-6, can be conditioned to environmental stimuli and, again, this
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conditioned effect is reduced by antagonism of either AMPA/kainate or NMDA receptors
within the NAC shell. This effect was evident at the mRNA, but not the protein level, in the
spleen. The ANOVA for splenic IL-6 mRNA levels revealed a significant antagonist
treatment by context interaction effect in [F(2,21)=4.021, p<0.05] but no antagonist
treatment or context main effects. Although the direction of the effect was as expected, the
ANOVA for splenic IL-6 protein levels did not indicate a significant antagonist treatment by
context interaction effect [F(2,21)=2.341, p=.121] or main effects. In line with our previous
experiments, the saline-treated group exposed to the previously heroin-paired environment
on the test day exhibited significantly lower levels of IL-6 mRNA in the spleen compared to
the saline-treated home cage control group (t(6)=3.923; P<0.01). Again, although the
expected effect for IL-6 protein was evident the t-test did not achieve statistical significance.
Conversely, there were no significant differences between the AP-5-treated or the CNQX-
treated group exposed to the previously heroin-paired environment and its respective home
cage control group in IL-6 mRNA levels in the spleen, showing that antagonism of either
AMPA/kainate or NMDA receptors within the NAC shell blocked the heroin-conditioned
suppression of LPSinduced IL-6 mRNA expression.
Heroin-conditioned suppression of nitric oxide production depends on the integrity of the
VTA-BLA-NAC circuit
Experiment 2 investigated the expression of heroin-induced conditioned suppression of pro-
inflammatory mediators following functional disconnection of a circuitry comprised of the
VTA, D1-receptor-bearing neurons in the BLA, and NMDA receptor-bearing neurons in the
NAC shell. On the test day, animals were re-exposed to the previously heroin-paired
environment for 60 min or remained in the home cage. To disconnect the above circuitry
prior to testing of the conditioned response, animals received a unilateral microinfusion of
the D1 antagonist, SCH23390, into the BLA coupled with a unilateral microinfusion of the
NMDA antagonist, AP-5, into the contralateral NAC shell. One control group received
ipsilateral infusions of SCH23390 into the BLA and AP-5 into the NAC. Additional control
groups received saline microinfusions into the contralateral or ipsilateral BLA and the NAC
shell.
Figure 5 shows the mean levels of LPS-induced iNOS mRNA expression in the spleen
(upper panel) and the LPS-induced nitrite/nitrate concentrations in the serum (lower panel)
for each group. The ANOVA for splenic iNOS mRNA levels revealed a significant
antagonist treatment by context interaction effect [F(2,24)=5.252, P<0.05], as well as
significant context F(1,24)=18.647, P<0.01] and antagonist treatment main effects
[F(2,24)=10.675, P<0.01]. Similarly, the ANOVA for serum nitrite/nitrate concentration
revealed a significant antagonist treatment by context interaction effect [F(2,24)=6.677,
P<0.05], as well as significant context [F(1,24)=8.737, P<0.01] and antagonist treatment
main effects [F(2,24)=8.474, P<0.01]. The saline-treated group exposed to the previously
heroin-paired environment on the test day exhibited significantly lower splenic iNOS copy
number and serum nitrite/nitrate concentration compared to the saline-treated home cage
control group (t(8)=6.884; P<0.01; t(8)=5.371; P<0.01, respectively). These data reconfirm
our earlier findings indicating that exposure to a previously heroin-paired environment
suppresses splenic iNOS mRNA expression and serum nitrite/nitrate levels. Similarly, the
group that received ipsilateral SCH23390 plus AP-5 treatment prior to exposure to the
previously heroin-paired environment exhibited significantly lower iNOS copy number and
nitrite/nitrate concentration compared to the ipsilaterally-treated home cage control group
(t(8)=5.131; P<0.01; t(8)=4.519; P<0.01, respectively). Most importantly, however, there was
no difference between the group that received contralateral SCH23390 plus AP-5 treatment
prior to exposure to the previously heroin-paired environment and the contralaterally-treated
home cage control group in iNOS copy number or nitrite/nitrate concentration. These
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findings indicate that functional disconnection of the VTA-BLA-NAC circuitry blocks the
heroin-conditioned suppression of LPS-induced nitric oxide production.
Heroin-conditioned suppression of TNF-α expression depends on the integrity of the VTA-
BLA-NAC circuitry
Figure 6 shows the mean levels of LPS-induced TNF-α expression for each group. The
ANOVA for splenic TNF-α mRNA levels revealed significant context [F(1, 24)=6.171,
P<0.05] and antagonist treatment main effects [F(1,24)=3.498, P<0.05] but no antagonist
treatment by context interaction effect. Furthermore, the ANOVA for TNF-α protein levels
revealed a significant context main effect [F(1,24)=5.06, P<0.05] but not antagonist
treatment main effect or antagonist treatment by context interaction effect. However,
planned comparisons indicated that the groups that received saline or ipsilateral SCH23390
plus AP-5 treatment prior to exposure to the previously heroin-paired environment exhibited
lower TNF-α mRNA (t(8)=3.711; P<0.01; t(8)=2.832; P<0.05, respectively) and protein
levels (t(8)=2.426; P<0.05; t(8)=2.312; P<0.05, respectively) compared to the respective
home cage control groups. Conversely, there were no differences between the groups that
received contralateral SCH23390 and AP-5 prior to exposure to the previously heroin-paired
environment and the respective home cage control group in TNF-α mRNA or protein levels.
These findings indicate that functional disconnection of the VTA-BLA-NAC circuitry
blocks the heroin-conditioned suppression of LPS-induced TNF-α expression.
Heroin-conditioned suppression of IL-6 expression depends on the integrity of the VTA-
BLA-NAC circuitry
Figure 7 shows the suppressive effect of heroin on IL-6 mRNA and protein expression in the
spleen for each group. The ANOVAs for splenic IL-6 mRNA and protein levels revealed
significant context main effects [F(1,24), P<0.01; F(1,24)=11.514, P<0.01, respectively] but
no antagonist treatment main or antagonist treatment by context interaction effect. However,
planned comparison revealed that the groups that received saline or ipsilateral SCH23390
plus AP-5 treatment prior to exposure to the previously heroin-paired environment exhibited
lower IL-6 mRNA expression (t(8)=4.12, P<0.01; one-tail t(8)=2.273; P<0.05, respectively)
and IL-6 protein levels (t(8)=4.569; P<0.01; one-tail t(8)=2.02; P<0.05, respectively)
compared to the respective home cage control groups. Conversely, there were no differences
between the groups that received contralateral SCH23390 and AP-5 prior to exposure to the
previously heroin-paired environment and the respective home cage control group in splenic
IL-6 mRNA and protein levels. These findings indicate that functional disconnection of the
VTA-BLA-NAC circuitry blocks the heroin-conditioned suppression of LPS-induced IL-6
expression.
4. Discussion
Although our laboratory and others have previously identified key brain areas involved in
conditioned immunomodulation, the experiments reported here are the first to identify a
specific neural circuit critical for the expression of the effects of heroin-related cues on
immune functioning. Specifically, they indicate that stimulation of ionotropic glutamate
receptors in the NAC shell as well as communication between the VTA, D1 dopamine
receptor-bearing neurons in the BLA, and NMDA receptor-bearing neurons in the NAC
shell are necessary for the ability of a heroin-paired context to suppress the production of
proinflammatory modulators in response to LPS immune challenge. The production of
proinflammatory modulators is a critical component of host immune response to pathogenic
challenge and any disruption of this process in current or recovering heroin users may
manifest as a decreased ability to combat infectious diseases even after achieving drug
abstinence. This, in turn, increases the risk of opportunistic infections and can result in other
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problems related to decreased immunity, such as deficient antibody responses to
vaccination.
The results of experiment 1 demonstrate that glutamatergic signaling within the NAC shell
plays a critical role in the conditioned effects of heroin on proinflammatory mediators. In
particular, antagonism of either NMDA or AMPA/kainate receptors within the NAC shell
blocked the expression of heroin-conditioned suppression of LPS-induced nitric oxide, TNF-
α, and IL-6 expression providing exciting new information regarding the role of the NAC in
heroin-induced conditioned immunomodulation. Similarly, NMDA or AMPA/kainate
receptor antagonism in the NAC prevents drug context-induced drug-seeking behavior (Xie
et al., 2011) and 7-OH-DPAT-conditioned place preference (Biondo et al., 2005),
conditioned behaviors based on associations between environmental stimuli and the primary
rewarding effects of 7-OH-DPAT. Together, these and the present findings indicate a
general role for NAC NMDA and AMPA receptors in Pavlovian conditioned responses,
including conditioned immunomodulatory responses.
Recent research from our laboratory revealed that antagonism of dopamine D1, but not D2,
receptors within the BLA blocks the conditioned effects of heroin on proinflammatory
mediators (Szczytkowski & Lysle, 2010). Importantly, the BLA directly innervates the NAC
via glutamatergic afferents (Wright & Groenewegen, 1995; Wright et al., 1996; Sesack &
Grace, 2010). Furthermore, functional disconnection studies have demonstrated that the
establishment of conditioned reinforcers and second-order Pavlovian conditioning are
dependent on interactions between the BLA and the NAC (Baldwin et al., 2000; Setlow et
al., 2002; Di Ciano & Everitt, 2004), supporting the hypothesis that communication within
the VTA-BLA-NAC circuitry may be necessary for the expression of conditioned
immunomodulation. To investigate this hypothesis, we used a functional disconnection
procedure (Setlow et al., 2002; Di Ciano & Everitt, 2004; Fuchs et al., 2007; Lasseter et al.,
2011). In addition, we took advantage of the fact that, in the rat, the primary source of
dopamine to the BLA is the VTA (Ford et al, 2006), in order to obtain a triple disconnection
manipulation. Accordingly, in experiment 2, unilateral intra-BLA administration of the D1
receptor antagonist, SCH23390, was coupled with contralateral intra-NAC shell
administration of the NMDA antagonist, AP-5, in order to functionally disconnect the VTA-
BLA-NAC neural circuit prior to the testing of the conditioned immune response.
Remarkably, functional disconnection of the VTA-BLA-NAC neural circuit blocked the
expression of heroin-conditioned suppression of the LPS-induced proinflammatory
response. Conversely, ipsilateral manipulation of the same neural circuit, which antagonizes
the same amount of neural tissue but leaves communication within the VTA-BLA-NAC
neural circuit intact in one hemisphere, failed to impair the heroin-conditioned suppression
of this proinflammatory response. These data indicate that sequential information processing
by the VTA, D1 dopamine-bearing neurons in the BLA, and NMDA receptor-bearing
neurons in the NAC shell is necessary for heroin-induced conditioned immunomodulation
and define, for the first time, a specific neural circuit involved in neural-immune
interactions.
It important to note that additional interactions between the VTA, BLA, and NAC and
communication with other brain regions are likely to critically contribute to heroin-induced
conditioned immunomodulation. Thus, further characterization of the larger neural circuit
responsible for this conditioned immune effect will be imperative. First, the present study
identifies the BLA as a necessary source of glutamatergic input to the NAC for the
expression of conditioned immunomodulation; however, the NAC receives glutamatergic
input from numerous other brain regions, including the dorsal hippocampus and prelimbic
cortex, which may be elements of the circuitry. In fact, preliminary studies in our laboratory
suggest that the dorsal hippocampus also plays a role in heroin-conditioned suppression of
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LPS-induced immune responses (Szczytkowski et al., unpublished observations). Future
disconnection studies will need to establish, however, whether the dorsal hippocampus
contributes to these responses as part of the currently known or a separate neural circuit.
Second, our laboratory has shown that intra-NAC shell administration of the dopamine D1
receptor antagonist, SCH23390, blocks the unconditioned effects of morphine and the
conditioned effects of morphine-paired environmental stimuli on natural killer cell activity
and nitric oxide production (Saurer et al., 2006; Saurer et al., 2009). Taken together with the
present findings, these data indicate that both glutamatergic and dopaminergic receptor
stimulation within the NAC is necessary for the expression of opioid-induced conditioned
immunomodulation. Furthermore, pyramidal cell projections from the BLA synapse in close
proximity to dopamine axons on medium spiny neurons of the NAC (Johnson et al., 1994,
Kelley et al., 1982 and Robinson & Beart, 1988), suggesting that conditioned immune
regulation may be a result of complex interaction between dopamine and glutamate within
the NAC. Third, the hypothalamus likely acts as an interface between the central nervous
system and autonomic centers that control peripheral immune response, including those
observed in the present study in the spleen and blood plasma. Consistent with this, various
hypothalamic nuclei exhibit robust Fos protein expression, a marker of neural activation, in
association with morphine-induced immunomodulation (Saurer & Lysle, unpublished
observation). Thus, future studies will ascertain whether neural activity within these regions
of the hypothalamus is also integral to opioid-conditioned immunomodulatory responses.
While the exact peripheral mechanisms modulating the alterations in proinflammatory
mediators observed in response to exposure to opioid-associated drug cues are unknown,
research has revealed potential mechanisms. Given the connectivity of the hypothalamus
with the autonomic nervous system and its control over the release of various peripheral
neuroendocrine mediators, this brain region may serve as the relay between the CNS and the
immune system. For example, cocaine-associated cues induce concomitant alterations in
immune functioning, including TNF-α production, and in corticosterone levels, suggesting
the HPA axis may be involved in drug cue-mediated conditioned immunomodulation
(Kubera et al., 2008). Alternatively, the sympathetic nervous system innervates both primary
and secondary lymphoid tissues and releases molecules that interact with receptors on
immune cells (Williams et al., 1981; Felten et al., 1984). In fact, sympathetic innervation of
the spleen provides some of the most concrete evidence for communication between the
nervous and immune systems through the release of norepinephrine (and other chemicals)
from sympathetic nerve fibers onto immune cells in this organ. In support of this possibility,
previous research from our laboratory has shown that the suppression of splenic mitogenic
responsiveness observed following exposure to an aversive CS can be blocked by
administration of the beta-adrenergic receptor antagonist, propanolol (Lysle et al., 1991).
Similarly, the expression of a subset of morphine-induced conditioned immune alterations is
blocked by systemic administration of the non-selective peripheral β-adrenergic receptor
antagonist, nadolol (Coussons-Read et al., 1994). The sympathetic nervous system may also
be involved in the unconditioned effects of morphine on immunity as beta-adrenergic
receptor antagonistm attenuate the morphine-induced suppression of lymphocyte
proliferation (Fecho et al., 1993). Furthermore, the conditioned and unconditioned effects of
opiates on NK cell cytotoxicity appears to be mediated by neuropeptide Y, a peptide
transmitter co-released with norepinephrine by the sympathetic nervous system (Saurer et al.
2006; 2008). Collectively these data suggest a possible role for the hypothalamus and the
sympathetic nervous system in the modulation of opiate-induced conditioned
immunomodulation.
Exposure to drug-associated environmental stimuli may have widespread implications for
the health outcomes of both current and former opiate users. For this reason, it is crucial that
the mechanisms by which previously heroin-paired stimuli alter the immune response are
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elucidated. A clear understanding of the neurotransmitters and neural circuitry involved in
heroin-conditioned immunomodulation will be needed for the targeted development of
pharmaceuticals that restore immune function in susceptible populations, allowing
pharmacotherapeutic intervention before infections lead to irreversible organ damage and
other detrimental health consequences. These effects need to be factored into the
comprehensive treatment – including substitution therapy and pain management – of both
current and former opiate users.
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Schematic representation of injection cannula placements. The symbols on the schematics
(Paxinos and Watson, 1997) represent the most ventral point of the infusion cannula tracts
for rats that received bilateral microinfusions into the NAC for experiment 1 (saline/home
cage: closed squares; saline/heroin-paired context: open squares; AP-5/home cage, closed
triangles; AP-5/heroin-paired context, open triangles; CNQX/home cage, closed circles;
CNQX/heroin-paired context, open circles). For experiment 2, symbols represent the most
ventral point of the infusion tract for rats receiving unilateral microinfusions into the BLA
plus the contralateral NAC (home cage, closed circles; heroin-paired context, open circles)
or the ipsilateral NAC (home cage, closed triangles; heroin-paired context, open triangles),
or a control microinfusion of saline into the BLA and NAC (home cage, closed squares;
heroin-paired context: open squares). Numbers indicate the distance from bregma in
millimeters.
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Effect of antagonist treatment and context on LPS-induced expression of iNOS mRNA in
the spleen as determined by real-time RT-PCR (top panel) and nitrite/nitrate production in
the serum as determined by the Greiss reagent assay (bottom panel). Exposure to the
previously heroin-paired context (Saline, white bar) resulted in conditioned suppression of
iNOS mRNA levels in the spleen and a conditioned suppression of the byproducts of nitric
oxide production in the serum as compared to the home cage control group (Saline, black
bar). Intra-NAC microinfusion of NMDA or AMPA/kainate receptor antagonist blocked the
effect of the conditioned stimulus (AP5/CNQX, white bar). Real-time RT-PCR data are
expressed as iNOS copy number per 10 ng cDNA based on a standard curve using Roche
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LightCycler software. Nitrite/nitrate data are expressed as the micromolar concentration of
nitrite/nitrate.
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Effect of antagonist treatment and context on LPS-induced expression of TNF-α mRNA in
the spleen as determined by real-time RT-PCR (top panel) and TNF-α protein levels as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context
(Saline, white bar) resulted in a conditioned suppression of TNF-α mRNA and protein
levels in the spleen as compared to the home cage control group (Saline, black bar). Intra-
NAC microinfusion of NMDA or AMPA/kainate receptor antagonist blocked the effect of
the conditioned stimulus (AP5/CNQX, white bar). Real-time RT-PCR data are expressed as
TNF-α copy number per 10 ng cDNA based on a standard curve using Roche LightCycler
software. ELISA data are expressed as pg of TNF-α protein per mg of total protein.
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Effect of antagonist treatment and context on LPS-induced expression of IL-6 mRNA in the
spleen as determined by real-time RT-PCR (top panel) and IL-6 protein in the spleen as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context
(Saline, white bar) resulted in a conditioned suppression of IL-6 mRNA levels in the spleen
as compared to the home cage control group (Saline, black bar). Intra-NAC microinfusion of
NMDA or AMPA/kainate receptor antagonist blocked the effect of the conditioned stimulus
(AP5/CNQX, white bar). Real-time RT-PCR data are expressed as iNOS copy number per
10 ng cDNA based on a standard curve using Roche LightCycler software. ELISA data are
expressed as pg of IL-6 protein per mg of total protein.
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Effect of antagonist treatment and context on LPS-induced expression of iNOS mRNA in
the spleen as determined by real-time RT-PCR (top panel) and nitrite/nitrate production in
the serum as determined by the Greiss reagent assay (bottom panel). Exposure to the
previously heroin-paired context (Saline, white bar) resulted in a conditioned suppression of
iNOS mRNA levels in the spleen and a conditioned suppression of the byproducts of nitric
oxide production in the serum as compared to the home cage control group (Saline, black
bar). Disconnection of the VTA-BLA-NAC circuit blocked the effect of the conditioned
stimulus (Contralateral, white bar). Ipsilateral administration of intra-NAC AP5 and intra-
BLA SCH23390 did not alter the conditioned suppression (Ipsilateral, white bar). Real-time
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RT-PCR data are expressed as iNOS copy number per 10 ng cDNA based on a standard
curve using Roche LightCycler software. Nitrite/nitrate data are expressed as the
micromolar concentration of nitrite/nitrate.
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Effect of antagonist treatment and context on LPS-induced expression of TNF-α mRNA in
the spleen as determined by real-time RT-PCR (top panel) and TNF-α protein levels as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context
(Saline, white bar) resulted in a conditioned suppression of TNF-α mRNA and protein
levels in the spleen as compared to the home cage control group (Saline, black bar).
Disconnection of the VTA-BLA-NAC circuit blocked the effect of the conditioned stimulus
(Contralateral, white bar). Ipsilateral administration of intra-NAC AP5 and intra-BLA
SCH23390 did not alter the conditioned suppression of TNF-α (Ipsilateral, white bar). Real-
time RT-PCR data are expressed as TNF-α copy number per 10 ng cDNA based on a
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standard curve using Roche LightCycler software. ELISA data are expressed as pg of TNF-
α protein per mg of total protein.
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Effect of antagonist treatment and context on LPS-induced expression of IL-6 mRNA in the
spleen as determined by real-time RT-PCR (top panel) and IL-6 protein in the spleen as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context
(Saline, white bar) resulted in a conditioned suppression of IL-6 mRNA and protein levels in
the spleen as compared to the home cage control group (Saline, black bar). Disconnection of
the VTA-BLA-NAC circuit blocked the effect of the conditioned stimulus (Contralateral,
white bar). Ipsilateral administration of intra-NAC AP5 and intra-BLA SCH23390 did not
alter the conditioned suppression of IL-6 (Ipsilateral, white bar). Real-time RT-PCR data are
expressed as IL-6 copy number per 10 ng cDNA based on a standard curve using Roche
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LightCycler software. ELISA data are expressed as pg of IL-6 protein per mg of total
protein.
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